NCT02323997View on ClinicalTrials.gov

Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study

CompletedOBSERVATIONAL
Enrollment

767

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions
Cervical Cancer
Trial Locations (10)

1206

Viollier Weintraub SA, Geneva

4123

Viollier AG, Allschwil

8002

Institute of Pathology Enge, Zurich

8024

Institut für klinische Pathologie Medica, Zurich

Unknown

Universitätsspital Basel, Basel

HUG - Hôpitaux Universitaires de Genève, Geneva

Kantonsspital Baselland, Liestal

Istituto cantonale di patologia, Locarno

Kantonsspital Luzern, Lucerne

Universitätsspital Zürich, Zurich

All Listed Sponsors
collaborator

Federal Office of Public Health, Switzerland

OTHER_GOV

lead

University of Bern

OTHER

NCT02323997 - Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study | Biotech Hunter | Biotech Hunter